Answers are grounded in this paper and cite their sources.
whole, these findings demonstrate the various biological roles of FBL, which go far beyond ribosome biogenesis and include development, aging, viral pathogenesis, autoimmunity, and cancer.4 Aberrant rRNA 2'-O-methylation patterns, together with transcriptional and genetic alterations in FBL, have increasingly been recognized as important regulators of cancer development and progression (Fig. 1).6 Emerging evidence indicates that rRNA 2'-O-methylation is not a constitutive structural mark but rather a dynamic epitranscriptomic modification.The cell's repertoire of proteins is shaped by these methylation events, which also affect ribosome assembly, structural stability, translational fidelity, and codon decoding efficiency.Functionally distinct ribosomes known as oncoribosomes can be produced by aberrant FBL-mediated rRNA methylation.These ribosomes preferentially translate transcripts related to cellular stress responses, metabolic adaptation, proliferation, and survival.This emerging concept helps explain how dysregulated FBL activity contributes to colorectal cancer (CRC) progression and offers a mechanistic framework connecting modified ribosome biogenesis with translational reprogramming.CRC is characterized by prominent nucleolar enlargement and increased protein synthetic demand, making dysregulated ribosome biogenesis a particularly relevant hallmark of disease progression.The enlarged and dysregulated nucleoli are hallmarks of cancer cells with increased ribosome biogenesis and high metabolic demands.FBL is a crucial regulator of ribosome biogenesis and a major contributor to tumorigenesis in several cancers, including CRC. 7 Aberrant FBL expression promotes the selective translation of oncogenic transcripts by altering ribosome structure, translational fidelity, and rRNA
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: